Tariff-driven input cost inflation
U.S. tariffs may increase the cost of raw materials and components used in products.
- Scope
- Manufacturing costs and gross margin
- Materiality
- high
IR-Med, Inc.
IR-Med, Inc. is a U.S.-based medical technology company in the electromedical and electrotherapeutic apparatus field. Based on its filings, the company appears to be developing and commercializing medical devices and related technologies, with operations exposed to manufacturing, sourcing, and regulatory execution risks.
0.38
0.38
| % | |
|---|---|
| Electromedical devices | 70% Medical devices that use electrical or electromagnetic technology for diagnosis or therapy. |
| Device development | 20% Engineering, prototyping, and product development activities for new medical technologies. |
| Manufacturing and sourcing | 10% Procurement of raw materials, components, and production support for device output. |
IR-Med’s customers are likely healthcare providers, distributors, and other medical-device channel partners that buy...
- Healthcare providersprimary
Hospitals, clinics, and medical practices that buy devices for clinical diagnosis or therapy.
- Distributors and channel partnerssecondary
Medical-device distributors that purchase inventory for resale into healthcare markets.
- International customerssecondary
Overseas buyers and partners whose demand is affected by trade policy, tariffs, and logistics.
IR-Med is headquartered in the United States, and its filings highlight exposure to U.S...
- •United States is the core operating and reporting base
- •Trade policy changes can affect imported components and costs
- •Supply chain may span foreign manufacturing and sourcing locations
- •Customer markets may include countries affected by tariffs
- •International logistics can influence production timing and margins
The company’s near-term focus appears centered on advancing product development while maintaining supply continuity and...
01
Supply-chain resilienceshort-term
Tariffs and trade tensions can raise costs or interrupt component availability.
02
Product commercializationmedium-term
A medical-device company needs successful development and market adoption to scale.
IR-Med faces material exposure to tariff changes, trade restrictions, and supply-chain disruption because its products...
Supply-chain disruption
Escalating trade tensions can delay sourcing, production, and delivery timelines.
- Scope
- Operations and customer fulfillment
- Materiality
- high
Commercialization and adoption risk
Medical-device products can face slow market acceptance and long sales cycles.
- Scope
- Revenue growth and operating leverage
- Materiality
- medium
Regulatory and compliance risk
Electromedical products typically require approvals and ongoing compliance oversight.
- Scope
- Product launch timing and market access
- Materiality
- medium
Inventory and input-cost accounting
Gross margin and working capital
Revenue recognition timing
Quarterly revenue comparability
Development cost treatment
Operating loss and asset balances
Impairment and reserve estimates
Earnings volatility
: 28.4.2026